Article
A model to predict severe HCV-related disease following liver transplantation.
Hepatology (Baltimore, Md.) - 1 Jul 2003
Berenguer Marina, Crippin Jeffrey, Gish Robert, Bass Nathan, Bostrom Alan, Netto George, Alonzo Judy, Garcia-Kennedy Richard, Rayón Jose-Miguel, Wright Teresa L
Abstract excerpt
Post-transplantation recurrence is increasing in patients with HCV. Early antiviral therapy may be of benefit in this setting. Thus, accurate and early prediction of progression may help select candidates for treatment. We developed a model based on pre- and/or early post-transplantation variables, which may predict progression to severe disease. Clinical and histologic outcomes were assessed in 554 liver...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.